EP 3687509 A1 20200805 - PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PERMEATION
Title (en)
PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PERMEATION
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT ERHÖHTER PERMEATION
Title (fr)
COMPOSITIONS PHARMACEUTIQUES À PERMÉATION AMÉLIORÉE
Publication
Application
Priority
- US 201715717856 A 20170927
- US 201715724234 A 20171003
- US 201862735822 P 20180924
- US 2018053026 W 20180927
Abstract (en)
[origin: WO2019067667A1] Pharmaceutical compositions having enhanced active component permeation properties are described.
IPC 8 full level
A61K 9/70 (2006.01); A61K 31/137 (2006.01)
CPC (source: EP IL KR)
A61K 9/006 (2013.01 - EP IL KR); A61K 9/7007 (2013.01 - EP IL KR); A61K 31/05 (2013.01 - EP IL); A61K 31/085 (2013.01 - EP IL); A61K 31/11 (2013.01 - EP IL); A61K 31/137 (2013.01 - EP IL KR); A61K 31/192 (2013.01 - EP IL); A61K 31/357 (2013.01 - EP IL); A61K 31/5513 (2013.01 - EP IL KR); A61K 31/5517 (2013.01 - EP IL KR); A61K 47/06 (2013.01 - KR); A61K 47/10 (2013.01 - KR); A61K 47/12 (2013.01 - KR); A61K 47/38 (2013.01 - KR); A61K 47/44 (2013.01 - KR); A61K 47/46 (2013.01 - KR); A61P 25/08 (2018.01 - KR); A61K 2300/00 (2013.01 - IL)
C-Set (source: EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2019067667 A1 20190404; BR 112020005967 A2 20201006; CA 3076815 A1 20190404; CN 111132670 A 20200508; EP 3687509 A1 20200805; IL 273479 A 20200531; JP 2020535176 A 20201203; JP 2024012484 A 20240130; JP 7431724 B2 20240215; KR 20200060457 A 20200529
DOCDB simple family (application)
US 2018053026 W 20180927; BR 112020005967 A 20180927; CA 3076815 A 20180927; CN 201880062717 A 20180927; EP 18786591 A 20180927; IL 27347920 A 20200322; JP 2020517586 A 20180927; JP 2023188095 A 20231102; KR 20207012033 A 20180927